ArticleFrontiers in pharmacology2024

Metformin's effect on metabolic dysfunction-associated steatotic liver disease through the miR-200a-5p and AMPK/SERCA2b pathway.

Hang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.